Real-World Use of Insulin Glargine u100 and u300 in Insulin-Naïve Patients with Type 2 Diabetes Mellitus: Dosinglar Study
mediaposted on 2021-05-24, 17:44 authored by Natalia Duque, Esther Artime, Irene Romera, Jeremie Lebrec, Silvia Díaz, Miriam Rubio, Antoni Sicras-Mainar, Enrique Carretero-Anibarro, Xavier Mundet, Juan J. Gorgojo-Martínez, Jesús Reviriego
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.